U.S. Pharmaceuticals & Biotech Mid-Large Cap Stocks

TG Therapeutics

Market Cap: US$4.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

ADMA Biologics

Market Cap: US$4.6b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

Medpace Holdings

Market Cap: US$8.4b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Exelixis

Market Cap: US$12.2b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Biogen

Market Cap: US$18.1b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Halozyme Therapeutics

Market Cap: US$6.0b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

ACADIA Pharmaceuticals

Market Cap: US$2.9b

A biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United States.

Tempus AI

Market Cap: US$11.2b

Operates as a healthcare technology company.

Kiniksa Pharmaceuticals International

Market Cap: US$1.8b

A biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide.

CG Oncology

Market Cap: US$1.8b

A late-stage clinical biopharmaceutical company, develops and commercializes backbone bladder-sparing therapeutics for patients with bladder cancer.

Arcutis Biotherapeutics

Market Cap: US$1.6b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

MoonLake Immunotherapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, focuses on developing therapies for inflammatory skin and joint diseases.

Mettler-Toledo International

Market Cap: US$23.2b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

United Therapeutics

Market Cap: US$13.5b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Structure Therapeutics

Market Cap: US$1.4b

A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Exact Sciences

Market Cap: US$10.4b

Provides cancer screening and diagnostic test products in the United States and internationally.

Dynavax Technologies

Market Cap: US$1.1b

A commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally.

Viridian Therapeutics

Market Cap: US$1.0b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

Merus

Market Cap: US$2.8b

A clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands.

Beam Therapeutics

Market Cap: US$1.7b

A biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States.

Bausch Health Companies

Market Cap: US$1.7b

Operates as a diversified specialty pharmaceutical and medical device company, develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health in the United States and internationally.

IDEAYA Biosciences

Market Cap: US$1.5b

A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.

Thermo Fisher Scientific

Market Cap: US$153.3b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Danaher

Market Cap: US$134.4b

Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.

Catalyst Pharmaceuticals

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States.

Regeneron Pharmaceuticals

Market Cap: US$60.4b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Belite Bio

Market Cap: US$2.0b

A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting retinal degenerative eye diseases with unmet medical needs in the United States.

Bio-Techne

Market Cap: US$7.5b

Develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide.

Immunocore Holdings

Market Cap: US$1.4b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

Incyte

Market Cap: US$11.8b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Akero Therapeutics

Market Cap: US$3.0b

Engages in the development of treatments for patients with serious metabolic diseases in the United States.

89bio

Market Cap: US$1.2b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Arrowhead Pharmaceuticals

Market Cap: US$2.1b

Develops medicines for the treatment of intractable diseases in the United States.

Disc Medicine

Market Cap: US$1.6b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Azenta

Market Cap: US$1.2b

Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.

GRAIL

Market Cap: US$1.2b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.